GEMAROMA Share Price Target 2035

CAGR-based price projection for Gem Aromatics Limited (GEMAROMA) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 98
2035 Target
Base Case (-17.3% CAGR)
Rs 28
2035 Target
Bull Case (-25.9% CAGR)
Rs 10
2035 Target

Current Market Snapshot

CMP: Rs 155.28
52W High: Rs 210.66
52W Low: Rs 149.10
1Y CAGR: -31.5%
3Y CAGR: -17.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 148 Rs 128 Rs 115
2028 Rs 140 Rs 106 Rs 85
2029 Rs 133 Rs 88 Rs 63
2030 Rs 126 Rs 73 Rs 47
2031 Rs 120 Rs 60 Rs 35
2032 Rs 114 Rs 50 Rs 26
2033 Rs 108 Rs 41 Rs 19
2034 Rs 103 Rs 34 Rs 14
2035 Rs 98 Rs 28 Rs 10

Other GEMAROMA Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the GEMAROMA share price target for 2035?

Based on historical growth analysis, the GEMAROMA share price target for 2035 ranges from Rs 98 (conservative) to Rs 28 (base case) to Rs 10 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GEMAROMA?

The current market price of GEMAROMA (Gem Aromatics Limited) is Rs 155.28. The 52-week high is Rs 210.66 and 52-week low is Rs 149.10.

Is GEMAROMA a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GEMAROMA price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-17.3% CAGR), and Bull (optimistic at -25.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.